Avoro Capital Advisors’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,500,000
| Closed | -$22.1M | – | 46 |
|
|
2023
Q2 | $22.1M | Hold |
3,500,000
| – | – | 0.3% | 31 |
|
|
2023
Q1 | $20.2M | Buy |
3,500,000
+1,227,778
| +54% | +$7.08M | 0.3% | 31 |
|
|
2022
Q4 | $23.3M | Buy |
2,272,222
+50,000
| +2% | +$513K | 0.35% | 31 |
|
|
2022
Q3 | $37.2M | Hold |
2,222,222
| – | – | 0.69% | 23 |
|
|
2022
Q2 | $31.1M | Hold |
2,222,222
| – | – | 0.61% | 26 |
|
|
2022
Q1 | $35.9M | Buy |
2,222,222
+586,122
| +36% | +$9.47M | 0.66% | 23 |
|
|
2021
Q4 | $35M | Buy |
1,636,100
+167,782
| +11% | +$3.59M | 0.6% | 26 |
|
|
2021
Q3 | $21.6M | Hold |
1,468,318
| – | – | 0.34% | 38 |
|
|
2021
Q2 | $26.4M | Hold |
1,468,318
| – | – | 0.46% | 33 |
|
|
2021
Q1 | $39.7M | Buy |
+1,468,318
| New | +$39.7M | 0.69% | 30 |
|